ABCL
AbCellera Biologics Inc. · Healthcare
Thermopylae Holdings Ltd. bought $9.0M of AbCellera Biologics Inc.
10% owner
Bought$9,021,801
$6.41Price
1,408,468Shares
+3%Stake
What ABCL did for a copier
- $1,000 copied at Mon, May 16 close, $7.81
- $1,294
- S&P 500, same days
- −4.5%
Measured over 30 trading days, to the Jun 29 close.
Thermopylae Holdings Ltd.'s record
7 other buys with 3 months of prices since 2021: on average +26.9% against the S&P 500, and 5 of 7 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, May 12. Filed Mon, May 16, 2:14 PM ET, during the session. Returns use the May 16 close and the Jun 29 close. Not investment advice.